Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,572 across all filing types
Latest filing 2020-02-06 Director's Dealing
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2020-02-06 English
PRIMARY DOCUMENT
Director's Dealing
2020-02-06 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 4, 2020, reporting the appointment of a new director to the Board of Directors of Illumina, Inc. The key section is Item 5.02, which specifically addresses the departure or election of directors or certain officers. The content describes the increase in board size and election of Scott Gottlieb as a director. There is no financial data or report attached; it is an announcement of a board/management change. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 3863 characters, which is consistent with a typical 8-K filing for management changes. Hence, the classification is MANG with high confidence.
2020-02-06 English
PRIMARY DOCUMENT
Director's Dealing
2020-02-05 English
PRIMARY DOCUMENT
Director's Dealing
2020-02-05 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 29, 2020, reporting the issuance of a press release announcing Illumina's financial results for the fourth quarter and fiscal year ended December 29, 2019. The text explicitly states that the press release is attached as Exhibit 99.1 and that the information is furnished under Item 2.02 (Results of Operations and Financial Condition). The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of the earnings information. According to the 'Menu vs Meal' rule, since this document is short (under 5,000 characters) and primarily announces the release of the earnings results via a press release, it should be classified as an Earnings Release (ER). The presence of the press release text as an exhibit supports this classification. Therefore, the filing type is Earnings Release (ER) with high confidence.
2020-01-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.